As of May 27
| -0.06 / -2.55%|
The 2 analysts offering 12-month price forecasts for Tonix Pharmaceuticals Holding Corp have a median target of 8.75, with a high estimate of 10.00 and a low estimate of 7.50. The median estimate represents a +282.10% increase from the last price of 2.29.
The current consensus among 3 polled investment analysts is to Buy stock in Tonix Pharmaceuticals Holding Corp. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.